Trial Profile
Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2012
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gallbladder cancer
- Focus Therapeutic Use
- 25 Jul 2012 Actual end date (1 May 2012) added as reported by University Hospital Medical Information Network - Japan.
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 14 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.